Navigation Links
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Date:12/16/2009

7';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.silence-therapeutics.com/">www.silence-therapeutics.com)

Silence Therapeutics plc (AIM: SLN) is a leading European RNAi-focused biotechnology company.

RNA interference (RNAi) is a Nobel Prize winning technology and one of the most exciting areas of drug discovery today. It represents a completely new approach to selectively 'silence' or inactivate disease relevant genes and as such it has the potential to create a new class of therapeutic products. RNAi could therefore offer a therapeutic approach to a broad range of diseases (cancer, infectious diseases, inherited diseases), many of which have been regarded as incurable and are not addressed by current therapeutics, therefore providing a large market opportunity.

Silence Therapeutics has developed a platform of novel short interfering RNA (siRNA) molecules, AtuRNAi, which provide a number of advantages over conventional siRNA molecules, including increased stability against nuclease degradation. In addition, the Company has developed a proprietary systemic delivery system, AtuPLEX. This system enables the functional delivery of siRNA molecules to targeted diseased tissues and cells, while increasing their bioavailability and intracellular uptake.

Following the granting of its patents in Europe, the USA and Australia, Silence Therapeutics is one of only two companies worldwide with a proprietary position on composition of matter for siRNA therapeutics.

Silence's lead internal product, Atu027, is a proprietary AtuRNAi molecule in clinical development for systemic cancer indications. Atu027 has successfully completed single and repeat dose toxicology and geno-toxicology studies, as well as a 28-day toxicology study using multiple dosing regimens. In June 2009, the Company started an open-label, single-centre, dose-escalation Phase I study with Atu027 in patients with advanced solid (m
'/>"/>

SOURCE Intradigm Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
2. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
3. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
4. Silence Therapeutics Announces Board Changes
5. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Regen BioPharma, Inc. (OTCBB: RGBP) and ... means of delivering its patented (US Patent 8,263,571) ... utilizing a clinically approved formulation as delivery system.  ... gene silencing therapeutics in which the gene silencing ... body.  By utilizing a local delivery system, potential ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , ... SNY ; EURONEXT: SAN) and the life sciences team ... improve care and outcomes for people with type 1 ... diabetes treatments and devices with Google,s expertise in analytics, ... will explore how to improve diabetes care by developing ...
(Date:8/31/2015)... 31, 2015  Qualcomm Incorporated (NASDAQ: QCOM ... Life, Inc., is collaborating with Davita Healthcare ... solutions powered by Qualcomm Life,s 2net™ Device Connectivity ... continuous care, informed interventions and better management of ... Life,s annual Connect 2015 ecosystem conference ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... (NYSE: CFN ), a leading, global medical ... to sell its OnSite Services instrument management and ... were not disclosed. (Logo:   http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) ... with our strategy to optimize our portfolio of businesses as ...
... 11, 2011 Reportlinker.com announces that a new ... Advanced Drug Delivery Markets (Liposomes, ... http://www.reportlinker.com/p0358466/Advanced-Drug-Delivery-Markets-Liposomes-Polymers-and-Monoclonal-Antibodies.html Drug delivery is evolving ... formulations being discovered frequently. Advanced drug delivery deals ...
Cached Medicine Technology:CareFusion Announces Sale of OnSite Services Instrument Management and Repair Business 2CareFusion Announces Sale of OnSite Services Instrument Management and Repair Business 3Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) 2Reportlinker Adds Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) 3
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Connectivity Kit is now available. With the Connectivity Kit, EasySampler data ... automated jacketed lab reactor control experiment, on a touchscreen platform. , EasySampler fully ...
(Date:9/1/2015)... ... September 01, 2015 , ... Mercy Health (formerly Catholic Health Partners) – a ... monthly Mercy Health: Helping You Be Well videos to prostate cancer awareness. Prostate cancer ... In a concise video on Mercy Health’s YouTube channel, Mercy Health experts address issues, ...
(Date:9/1/2015)... ... September 01, 2015 , ... Ogawa’s new massage chairs tout innovative functionality ... and humanlike than ever before. With the goal of bringing wellness to the world, ... Active SuperTrac. , As in its name, the Ogawa Refresh aims ...
(Date:9/1/2015)... ... September 01, 2015 , ... USA Medical Card, ... this week to coincide with back-to-school and the start of “sick season” for ... CDC, elementary school children are sick an average of 8 to 12 times ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... popular VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of ... pillars: Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy acids ...
Breaking Medicine News(10 mins):Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3
... Queensland research is showing the benefits of resistance training in ... Tim Henwood, a postdoctoral research fellow with UQ and Blue ... over the age of 65 responded to resistance training. ... training can improve muscle strength, power and functional performance." Dr ...
... and ethical issues facing medical physicists are numerous and ... of medicine. Certain activities, such as handling radioactive materials, ... Other activities, such as minimum education and training standards ... , A number of distinguished speakers will help dissect ...
... Focus Through ... Extending the Good Baby Product Line, PLYMOUTH ... BJGP; "BMP Sunstone"; the "Company") today,announced that its wholly-owned ... non-binding letter of,intent to acquire 75 percent of Zhangjiakou ...
... U.S. babies born with hearing loss, experts note , , FRIDAY, ... recommending that all newborns be screened for congenital hearing loss. ... newborn infant,s health care evaluation," U.S. Preventive Services Task Force ... the Colorado Department of Public Health and Environment, said in ...
... Patient Education System that provides hospitals, medical centers and clinics with ... a telephone, pillow speaker, interactive touch screen or computer. , ... ... Systems recently launched several new interface options to it's popular ...
... 17 William F. McMurry, a,Nationally Board Certified ... final Court approval of a settlement in the,first ... Kentucky state court,judge. The settlement gives economic and ... annuities. The Settlement is valued at approximately,$16,400,000., ...
Cached Medicine News:Health News:The benefits of a little resistance for older adults 2Health News:Legal and ethical issues in medical physics 2Health News:Legal and ethical issues in medical physics 3Health News:Legal and ethical issues in medical physics 4Health News:Legal and ethical issues in medical physics 5Health News:Legal and ethical issues in medical physics 6Health News:Legal and ethical issues in medical physics 7Health News:BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co. 2Health News:BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co. 3Health News:All Newborns Should Have Ears Screened, Task Force Says 2Health News:Synergy Broadcast Systems Announces Enhancements to MMDS Patient Education System 2Health News:Synergy Broadcast Systems Announces Enhancements to MMDS Patient Education System 3Health News:William F. McMurry - Lead Class Counsel Obtains $16.4 Million Settlement for Elderly Clients 2
High speed, programmable refrigerated centrifuge. High efficiency separations, "Like clockwork" accuracy, aerosol containment, Accommodating, Re-Run control, Glove-Friendly membrane, centrifuge statu...
... 460 family of centrifuges ... that meets a wide ... feature high capacity, versatility ... technology and high safety ...
The Quantum performs centrifugal blood cell separations, urine separations, and sperm cell washing. 24 place angle head, variable speed, and automatic braking system, calibrated variable speed....
... centrifuge is designed especially for ... cover with safety interlock switch, ... emissions, "hold" position for continuous ... motor, maximum stability and compact, ...
Medicine Products: